# Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia

> **NCT00515879** · PHASE3 · COMPLETED · sponsor: **Boston University Charles River Campus** · enrollment: 169 (actual)

## Conditions studied

- Social Anxiety Disorder

## Interventions

- **DRUG:** D-cycloserine
- **BEHAVIORAL:** Cognitive behavioral therapy (CBT)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00515879
- **Lead sponsor:** Boston University Charles River Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2019-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00515879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00515879, "Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00515879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
